(Q45928405)

English

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis.

scientific article published on 15 July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

1 reference

based on heuristic

inferred from title

Hiroharu Yamashita

10

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

author name string

H Ishigami

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

J Kitayama

2

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

S Kaisaki

3

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

A Hidemura

4

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

M Kato

5

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

K Otani

6

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

T Kamei

7

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

D Soma

8

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

H Miyato

9

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

H Nagawa

11

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

language of work or name

1 reference

based on heuristic

inferred from title

publication date

15 July 2009

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

21

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

1

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

67-70

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Disparities in gastric cancer chemotherapy between the East and West

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Phase II study of sequential methotrexate and 5-fluorouracil chemotherapy against peritoneally disseminated gastric cancer with malignant ascites: a report from the Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group, JCOG 960

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

A Phase II study of oxaliplatin with low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) for gastric cancer patients with malignant ascites

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Chemotherapy for metastatic disease: review from JCOG trials

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Prevention of peritoneal metastasis of human gastric cancer cells in nude mice by S-1, a novel oral derivative of 5-Fluorouracil

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Pharmacokinetic study of paclitaxel in malignant ascites from advanced gastric cancer patients

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Phase I and pharmacokinetic study of S-1 combined with weekly paclitaxel in patients with advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Intraperitoneal administration of paclitaxel and oral S-1 for a patient with peritoneal dissemination and hydronephrosis due to advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Japanese Classification of Gastric Carcinoma - 2nd English Edition -

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Paclitaxel-induced apoptosis in human gastric carcinoma cell lines.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDP260

21 January 2018

Identifiers

10.1093/ANNONC/MDP260

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 December 2017

http://europepmc.org/abstract/MED/19605503

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45928405&oldid=1620018864"